Vivendi’s deal to buy out rival Lagardere is now is likely to face a full-scale EU antitrust investigation, reported Reuters.
The acquisition would combine France’s two largest publishing groups, Lagardere’s Hachette and Vivendi’s Editis, and has come in for criticism from rivals including Gallimard.
Bollore is Vivendi’s controlling shareholder with a 29% stake. The mass media holding company already owns 57% of Lagardere after a bid for all of the group’s shares.
Read more: EU Antitrust Watchdog To Rule On Vivendi’s Lagardere Deal By Nov. 30
To resolve European Union antitrust concerns billionaire Vincent Bollore, would sell all Editis shares he would receive after the transaction, which would consist of a simultaneous distribution of the publishing unit’s shares to Vivendi shareholders and its listing.
The move aims to remove the entire overlap between Vivendi and Lagardere, one of the people said. It was not impossible that Vivendi may formally offer remedies in a bid to secure approval during the EU preliminary review but the short period of time left for regulators to do their work during this phase was a constraint, the person said.
The European Commission is expected to launch an in-depth investigation after finishing its preliminary review of the deal on Nov. 30, the sources said.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI